Endothelial cells (ECs) are of great value for cell therapy, tissue engineering, and drug discovery. Obtaining high-quantity and -quality ECs remains very challenging. Here, we report a method for the scalable manufacturing of ECs from human pluripotent stem cells (hPSCs). hPSCs are expanded and differentiated into ECs in a 3D thermoreversible PNIPAAm-PEG hydrogel. The hydrogel protects cells from hydrodynamic stresses in the culture vessel and prevents cells from excessive agglomeration, leading to high-culture efficiency including high-viability (>90%), high-purity (>80%), and high-volumetric yield (2.0 3 10 7 cells/mL). These ECs (i.e., 3D-ECs) had similar properties as ECs made using 2D culture systems (i.e., 2D-ECs). Genome-wide gene expression analysis showed that 3D-ECs had higher expression of genes related to vasculature development, extracellular matrix, and glycolysis, while 2D-ECs had higher expression of genes related to cell proliferation.
INTRODUCTION
Endothelial cells (ECs) are major components of blood vessels (Carmeliet, 2001; Richards et al., 2010) . They are of great value for disease modeling, drug screening, cell therapy, and tissue engineering (Heo et al., 2014; Huang et al., 2013; Kang et al., 2013; Leung et al., 2016; Medina et al., 2010; Moubarik et al., 2011; Patsch et al., 2015; Schwarz et al., 2012; Stroncek et al., 2012) . However, obtaining large numbers of primary ECs for those applications, in particular for clinical applications (Arici et al., 2015; Chao et al., 2014; den Dekker et al., 2011; Granton et al., 2015; Matoba et al., 2008) , is still challenging due to their limited proliferation capacity and phenotype changes during the in vitro culture (van Beijnum et al., 2008; de Carvalho et al., 2015; Gui et al., 2009; Gumbleton and Audus, 2001; Hayflick, 1965; Augustin-Voss et al., 1993) . Human pluripotent stem cells (hPSCs) provide a potential solution to this challenge (Levenberg et al., 2007) . hPSCs, including human embryonic stem cells (hESCs) (Thomson et al., 1998) and induced pluripotent stem cells (iPSCs) (Takahashi et al., 2007; Yu et al., 2007) , have unlimited proliferation capacity and can be efficiently differentiated into ECs through 3D embryonic body (EB)-based (Condorelli et al., 2001; James et al., 2010; Levenberg et al., 2002 Levenberg et al., , 2007 Li et al., 2009a Li et al., , 2009b Nourse et al., 2010) or 2D monolayer culture-based protocols (Cao et al., 2013; Kane et al., 2010; Palpant et al., 2016; Patsch et al., 2015; Vodyanik et al., 2005) . In addition, cells derived from patient-specific iPSCs have the patient's genetic information and can model many human diseases. Further, they induce minimal immune response in vivo (Lalit et al., 2014) . These hPSC-derived ECs have the potential to provide unlimited cell sources for the applications.
While making small-scale hPSC-derived ECs in laboratories can be readily done (Giacomelli et al., 2017; Lian et al., 2014; Orlova et al., 2014; Palpant et al., 2016; Zhang et al., 2017a) , generating or manufacturing large numbers of ECs from hPSCs has not been achieved. Current 2D culture methods, in which cells are cultured as adherent cells on 2D surfaces (e.g., cell culturing flasks), are labor, time, and cost intensive, and not suitable for culturing cells on a large scale (Jenkins and Farid, 2015; Kropp et al., 2017) . 3D suspension culture methods (e.g., using stirred-tank bioreactors), in which cells are suspended in an agitated culture medium, have been considered a potential solution for scaling up the cell production (Jenkins and Farid, 2015; Kropp et al., 2017; Lei and Schaffer, 2013) . However, recent research has shown that culturing cells on a large scale with 3D suspension cultures is also very challenging (Lei et al., 2014; Serra et al., 2012; Steiner et al., 2010; Wurm, 2004) . hPSCs in 3D suspension cultures frequently aggregate to form large cell agglomerates (Kropp et al., 2017) . The mass transport to cells located at the center of large agglomerates (e.g., >400 mm diameter) becomes difficult, leading to slow cell growth, cell death, and uncontrolled differentiation (Kropp et al., 2017) . While agitating the culture can reduce cell agglomeration, it also generates hydrodynamic stresses, which are adverse to the cell's physiology (Fridley et al., 2012; Kinney et al., 2011; Kropp et al., 2017) . As a result, 3D suspension culturing has significant cell death, low cell growth, and low volumetric yield (Lei and Schaffer, 2013) . For instance, hPSCs typically expand 4-fold in 4 days to yield around 1.0 3 10 6 to 2.0 3 10 6 cells/mL, which occupy 0.4% of the bioreactor volume (Lei et al., 2014; Serra et al., 2012; Steiner et al., 2010; Wurm, 2004) .
To address the challenge, we previously developed a scalable, efficient, and current Good Manufacturing Practice (cGMP)-compliant method for expanding hPSCs (Lei and Schaffer, 2013; Li et al., 2016; Lin et al., 2017) . The method, which was successfully repeated in this study (Figures 1 and S2) , uses a 3D thermoreversible hydrogel (Mebiol Gel) as the scaffold. Single hPSCs are first suspended in a liquid PNIPAAm-PEG polymer solution at low temperature (e.g., 4 C). Upon heating to 20 C-37 C, the polymer solution forms an elastic hydrogel matrix, resulting in single hPSCs encapsulated in the hydrogel matrix. After culturing for about 4-5 days, these single hPSCs clonally grow into spherical cell aggregates (spheroids) with very uniform size ( Figures 1B, S2A , and S2D). The hydrogel can be quickly liquefied through cooling to 4 C to harvest the cells for the next passage ( Figure 1A ).
The hydrogel scaffold protects cells from hydrodynamic stresses in the culture vessel and prevents cells from excessive agglomeration, leading to high culture efficiency. For instance, the hydrogel scaffold enables long-term, serial expansion of hPSCs with a high cell viability (e.g., >90%, Figures 1D, S2C , and S2F), growth rate (e.g., 20-fold/5days, Figure 1E ), yield (e.g., 2.0 3 10 7 cells/mL, Figure 1F ), and purity (>99%, Figure 1C , S2B, and S2E), all of which offer considerable improvements over 3D suspension cultures (Lei and Schaffer, 2013; Li et al., 2016; Lin et al., 2017) . We hypothesize that hPSCs can also be differentiated into ECs in this culture system. In this paper, we successfully tested the hypothesis. Together, we developed a scalable bioprocess for making highquality ECs with high volumetric yield, high viability, and high purity (>80%).
RESULTS

Differentiation of hPSCs into ECs in 2D Adherent Cultures
We used H9 hESCs, iPSCs reprogrammed from human dermal fibroblasts (i.e., Fib-iPSCs), and iPSCs reprogrammed from mesenchymal stem cells (i.e., MSC-iPSCs) (Park et al., 2008) , for this study. All formed compact colonies when cultured on Matrigel-coated plates in the chemical-defined Essential 8 (E8) medium (Figures S1A, S1E, and S1I). They expressed pluripotency makers OCT3/4 and NANOG (Figures S1B, S1F, and S1J), and could be differentiated into all three germ layer cells (e.g., NESTIN+ ectodermal, a-SMA+ mesodermal, and HNF-3b+ endodermal cells) in EB assay (Figures S1C, S1G, and S1K). They also formed teratomas containing all three germ layer tissues in immunodeficient mice (Figures S1D, S1H, and S1L). Patsch et al. (2015) recently reported a protocol that could efficiently generate ECs from hPSCs in 6 days in 2D cultures. This protocol is simple and quick, and thus it is very appealing for making high-quantity ECs. We successfully repeated this protocol with our H9s and iPSCs (Figure S3) . The produced ECs had the typical EC cobblestone morphology (Figures S3B and S3H) . Immunostaining showed that the majority of these cells expressed the EC markers PECAM1 (or CD31) and VE-Cadherin (or CD144) (Figures S3C and S3I) . Flow cytometry analysis showed that about 80% cells were positive for the two markers ( Figures S3D and S3J) . A small fraction of produced cells was positive for SM22A and CD140b, markers for smooth muscle cells ( Figures S3E, S3F , and S3K). We did not detect any undifferentiated OCT3/4+ and NANOG+ hPSCs ( Figures S3G and S3L ). H9s and iPSCs had similar outcomes ( Figure S3 ). Our results were very similar to these reported by Patsch and Cowan, indicating the robustness of the differentiation protocol (Patsch et al., 2015) . We termed ECs made in 2D culturing as 2D-ECs.
Differentiation of hPSCs into ECs in 3D Thermoreversible PNIPAAm-PEG Hydrogels
We then applied the protocol to differentiate hPSCs in the 3D thermoreversible hydrogels (Figure 2A ). Single hPSCs were encapsulated into the gel and expanded for 5 days to generated hPSC spheroids with a diameter of around 150 mm. Differentiation was initiated on day 0 by switching the expansion medium to the differentiation medium (Figure 2B) . Live/dead cell staining showed that the majority of cells on day 5 were live ( Figure 2C ). Immunostaining and confocal imaging showed that the majority of cells in the day 5 spheroids were positive for EC markers PECAM1 and VE-Cadherin ( Figure 2D ). ECs were uniformly distributed, and no cysts were found in the spheroids, indicating no or little cell death in the spheroids. Flow cytometry analysis found that about 84% of the cells were PECAM1+ and VE-Cadherin+ ( Figure 2E ). About 1.6 3 10 7 cells and 2.0 3 10 7 cells were produced in each milliliter of hydrogel on day 0 and 5, respectively ( Figure 2F ). Thus, about 20 cells were generated from one input hPSC on day 5. When the day 5 EC spheroids were dissociated into single cells and plated on Matrigel-coated plates at high density, they formed tight cell-cell interactions (Figure 2G) . Immunostaining detected small numbers of SM22A+ cells ( Figure 2H ), and flow cytometry analysis found that about 13.8% of cells were CD140b+ ( Figure 2I ). Single hPSCs are mixed with 10% PNIPAAm-PEG solution at low temperature (e.g., 4 C), which forms an elastic hydrogel at 37 C. Single hPSCs clonally expand into uniform spheroids in the hydrogel in 5 days. Upon cooling to 4 C, the hydrogel is liquefied, and spheroids are harvested and dissociated into single cells for the next expansion (i). Once the targeted cell number is reached, hPSCs are differentiated into ECs in the hydrogel (ii). (E and F) About 5-, 10-, and 20-fold expansion (E), yielding 5, 10, and 20 million cells per milliliter of hydrogel (F) on day 3, 4, and 5, is achieved for H9s, Fib-iPSCs, and MSC-iPSCs. Data are represented as mean ± SD of three independent replicates (n = 3).
No undifferentiated OCT3/4+ and NANOG+ hPSCs were detected ( Figure 2J ). The majority of cells were PECAM1+/ VE-Cadherin+ ( Figure 2K ). Fib-iPSCs and MSC-iPSCs had similar outcomes ( Figures S4 and S6) . We found the differentiation efficiencies in the 3D hydrogel and the conventional 2D culture were very close (Figures 2 and S3) . We termed ECs made in the hydrogel and that had not been cultured on any 2D surfaces as 3D-ECs.
Properties of hPSC-Derived ECs
Our culture system provides a 3D microenvironment for hPSC growth and differentiation. Recent studies found that the 3D microenvironment could alter the cell phenotype and functional properties compared with those cultured in 2D (Zhang et al., 2017b; Zujur et al., 2017) . We thus asked if the 3D-ECs and 2D-ECs were similar in phenotype, function, and gene expression. Using fluorescently labeled acetylated LDL and microscope imaging, we found that they had a similar capacity to uptake lipids ( Figure 3A ). In the classical tube formation assay, they could form vascular network-like structures ( Figure 3B ). Through quantification with the Angiogenesis Analyzer of ImageJ (Fork et al., 2015) , we found 3D-ECs had higher tube length and branching counts than 2D-ECs ( Figure 3C ). When ECs were co-cultured with vascular smooth muscle cells, they could arrange in highly organized structures ( Figure 3D ). The trans-endothelial electrical resistance (TEER) analysis (Srinivasan et al., 2015) revealed that both formed tight barriers as shown by the high TEER value. The barrier tightness was disrupted by tumor necrosis factor alpha, interleukin-1b (IL-1b), and vascular endothelial growth factor A (VEGFA), as shown by a sharp decrease of TEER values. Importantly, 3D-ECs and 2D-ECs performed very similar to primary human umbilical vein endothelial cells (HUVECs) ( Figure 3E ). To test the angiogenic potential of 3D-ECs and 2D-ECs in vivo, we injected them subcutaneously with a Matrigel matrix into immunodeficient mice. H&E staining and immunostaining revealed similar blood vessel density and structure in the matrix for 3D-ECs and 2D-ECs ( Figures 3F and 3G ). We also used qPCR to quantitatively analyze the expression of a few EC-specific genes including the surface markers (CD31, CD144, VWF, and CD34), growth factors (VEGFA, VEGFB, and VEGFC), and extracellular matrix (ECM) (FN and COL4A) . The results showed that the 3D microenvironment enhanced the expression of these genes ( Figures  3H and 3I) . Similar results were found for iPSC-derived ECs ( Figure S5 ).
Whole Transcriptome Analysis of 3D-ECs and 2D-ECs Derived from H9s
The above qPCR findings drove us to study the genomewide gene expression difference using RNA sequencing (RNA-Seq). We sequenced the undifferentiated H9s, 3D-ECs, and 2D-ECs derived from H9s (three biological replicates for each). Hierarchical clustering analysis ( Figure 4A ) and principal component analysis (PCA) (Figure 4B) showed that 3D-ECs and 2D-ECs clustered closely and were very different from H9s. The genome-wide gene expression profile correlation coefficients between 3D-ECs and 2D-ECs were >0.83, indicating similar global gene expressions ( Figures 4C and 4D) . However, the separation of 2D-ECs and 3D-ECs in PC2 of the PCA indicated that these cells had some differences in gene expressions ( Figure 4B ), which drove us to perform detailed differential gene expression analysis.
Differential gene expression analysis identified 919 genes upregulated in 3D-ECs, and 718 genes upregulated in 2D-ECs (Data S1). Gene ontology term analysis showed that genes enriched in 3D-ECs are related to vasculature development, ECM assembly and cell adhesion, glycolysis, and ephrin and Notch signaling. Genes enriched in 2D-ECs are related to mitotic cell-cycle process genes and ECM disassembly ( Figure 5A ). These results indicated that 2D-ECs adopted a proliferative phenotype, while the 3D environment promoted vascular morphogenesis.
Detailed gene expression analysis (Data S2) showed the following differences: (1) 3D-ECs had higher expression of ECM genes including collagen (COL23A1, COL20A1, COL13A1, COL11A2, COL6A6, COL6A3, COL14A1, COL24A1, COL4A4, COL16A1, COL25A1, COL27A1, COL5A1, COL6A5, COL4A3, COL7A1, COL4A6, and We did further tests to study if the differences found in the RNA-seq data analysis could also be found in cell phenotype or function assays. Western blotting analysis showed that 3D-ECs had higher expressions for CD31, CD144, FN, NOTCH4, and ITGA2 than 2D-ECs ( Figure 6A ). Using Ki67 immunostaining and flow cytometry analysis, we found more cells were proliferating in 2D-ECs than in 3D-ECs (Figures 6B and 6C) . Glycolysis analysis showed that 3D-ECs had higher glycolytic rate than 2D-ECs ( Figure 6D ). The in vitro tube formation assay already showed that 3D-ECs had longer tubes and more branches ( Figure 3C ). Similar . Data are represented as means ± SD of three independent replicates (n = 3). Scale bars, 50 mm. *p < 0.05, **p < 0.01. (E) TEER properties of HUVECs, 3D-ECs and 2D-ECs, either untreated or treated with 100 ng/mL tumor necrosis factor alpha (TNF-a), 100 ng/mL IL-1b, or 100 ng/mL VEGFA, are similar. Data are represented as means ± SD of three independent replicates (n = 3). ***p < 0.001. (F and G) When transplanted subcutaneously with a Matrigel matrix, 2D-ECs (F) and 3D-ECs (G) form vascular structures. Scale bars, 100 and 25 mm. (H and I) qRT-PCR shows that 3D-ECs have higher expression of some key genes related to ECs, including EC markers (H), growth factors and ECM genes (I). Data are represented as means ± SD of three independent replicates (n = 3). ***p < 0.001. results were found in ECs derived from iPSCs (Figures S5 and S6) . These in vitro phenotypic analyses well supported the RNA-seq data (Figures 5 and S7) . However, the in vivo Matrigel Plug Assay did not find significant differences in terms of the vascular density and branches for 3D-ECs and 2D-ECs ( Figures 3F, 3G , and S5E). This indicates that the gene expression and in vitro phenotype differences are not sufficient to generate functional differences in vivo. Alternatively, the Matrigel Plug Assay is not sensitive enough to detect the functional differences in vivo. The functional differences of 3D-ECs and 2D-ECs, such as integration and potency, should be systematically studied with disease (e.g., limb ischemia model) or developmental models in the future (Cooke and Losordo, 2015; Tang et al., 2011) .
Scalable Production of hPSC-ECs in Suspension with the Hydrogel Scaffold
All the above studies were performed by casting the thermoreversible hydrogel (with cells encapsulated) as a thin layer (e.g., 500-1,000 mm thickness) on cell culture plates (e.g., 6-well plates). We also demonstrated that the hydrogel could be processed into small fibers (with cells encapsulated in the fibers) for suspension culturing ( Figure 7A ). It is generally accepted that 3D suspension culturing is more suitable for large-scale production of cells. On day 0, single hPSCs (4.0 3 10 6 cells) were mixed with 4 mL 10% PNIPAAm-PEG solution at 4 C and injected into room temperature E8 medium contained in a closed and sterile bioreactor (e.g., a 50-mL conical tube). Fibrous hydrogels were instantly formed with single hPSCs uniformly distributed in the hydrogels. Cells were cultured in a cell culture incubator at 37 C and 5% CO 2 . The medium was stocked in a gas-permeable bag and continuously perfused into the bioreactor. Perfusion instead of stirring was used to mix the medium since the hydrogel fibers were soft and stirring resulted in fiber breakage. Cells were expanded for 5 days and then differentiated for 5 days. On day 10, hydrogel scaffolds were liquefied, and cell spheroids were pelleted by spinning for 5 min at 100 3 g. Spheroids were dissociated into single cells by treating with Accutase at 37 C for 10 min. About 8.0 3 10 7 ECs were produced. Magnetic beads coated with anti-CD144 antibodies were then added to the conical tube to pull down the ECs with a magnetic cell separator ( Figure 7B ). Live/dead cell staining showed that the majority of the cells were live (Figure 7C) . Immunostaining and flow cytometry analysis showed that 81.3% of the day 10 cells were ECs (Figures 7D and 7E) . When transplanted subcutaneously with a Matrigel matrix, ECs formed nice vascular structures ( Figure 7F ).
DISCUSSION
Currently, hPSC-derived ECs are made either in 2D culture or as EBs in 3D suspension culture. Both have difficulty to cost-effectively generate large numbers of high-quality ECs required for drug discovery, tissue engineering, and cell therapies. Both culture methods provide culturing conditions that are very different from the in vivo 3D microenvironments where cells reside (Chen et al., 2014a (Chen et al., , 2014b Kraehenbuehl et al., 2011; Thomson et al., 1998; Wong et al., 2010) . 2D culturing is labor, space, and reagent consuming and considered only suitable for preparing low-scale cells (e.g., %10 9 ) (Kropp et al., 2017) .
3D suspension culturing has been widely studied to scale up the production of hPSCs and their derivatives (Fridley et al., 2012; Kinney et al., 2011; Kropp et al., 2017) . However, hPSCs in suspension culturing suffer from severe cellular agglomeration (Fridley et al., 2012; Kinney et al., 2011; Kropp et al., 2017) . The strong cell-cell interactions make hPSCs form large agglomerates (i.e., agglomeration) that lead to culture inhomogeneity, impaired mass transport, and low culture efficiency (Fridley et al., 2012; Kinney et al., 2011; Kropp et al., 2017) . Agitation (stirring or shaking) the culture can reduce agglomeration and enhance mass transport (Fridley et al., 2012; Kinney et al., 2011; Kropp et al., 2017) . However, agitation generates complicate hydrodynamic conditions including medium flow direction, velocity, pressure, shear force, and chemical environment. These physical and chemical microenvironments vary spatially and temporally, generating critical stresses in some locations (e.g., near vessel wall and impeller tip), which induce cell death and phenotype changes (Fridley et al., 2012; Ismadi et al., 2014; Jenkins and Farid, 2015; Kinney et al., 2011; Kropp et al., 2017; Lei and Schaffer, 2013; Lei et al., 2014; Serra et al., 2012; Steiner et al., 2010) .
These physical and chemical microenvironments are sensitive to many factors, such as the bioreactor design (e.g., impeller geometry, size and position, vessel geometry and size, positions of probes for pH, temperature, and oxygen), the medium viscosity and agitation rate (Ismadi et al., 2014; Kropp et al., 2017) . They are currently not well understood and hard to control (Fridley et al., 2012; Ismadi et al., 2014; Kinney et al., 2011; Kropp et al., 2017) . In addition, how these physical and chemical factors, individually or combined, influence different types of cells is not well understood and hard to study. These knowledge gaps lead to large culture variations between batches as well as difficulty in scaling up. The challenge of using 3D suspension culturing for large-scale cell production is well demonstrated by a few recent studies on producing hPSC-derived cardiomyocytes in stirred-tank bioreactors (Chen et al., 2015; Jara-avaca et al., 2014) . For three independent batches (100 mL culture volume) with HES3 hESCs, both the yield and product purity varied in large ranges (e.g., from 40 million to 100 million cells for the yield, and from 54% to 84% for the cardiomyocyte purity). Using the same bioreactor and a different hPSC line, the final yield ranged from 89 million to 125 million cells, and final cardiomyocyte purity ranged from 28% to 88% (Chen et al., 2015; Jara-avaca et al., 2014) . In addition, when culture volume was scaled from 100 to 1,000 mL, the yield and differentiation efficiency were significantly changed (Chen et al., 2015; Jara-avaca et al., 2014) . This makes scaling up very challenging since optimizing multiple factors in large culture volumes is costly. To the best of our knowledge, the largest demonstrated culture volume for hPSCs and their derivative in literature is less than 10 L (Kempf et al., 2016; Kropp et al., 2017) . In short, the uncontrolled cell aggregation and hydrodynamic stress/conditions make it difficult to culture hPSCs and their derivatives on a large scale with 3D suspension culturing.
The thermoreversible hydrogel scaffold used in this paper not only provides 3D space for cell growth, but also acts a physical barrier to prevent cell agglomeration and isolate the shear force (Figure 1 ). Eliminating these negative factors leads to significantly enhanced culture efficiency. We showed that ECs could be produced with high viability, high purity (>80%), and high yield (2.0 3 10 7 cells/mL hydrogel) within 10 days. For comparison, it usually yields 1.0 3 10 6 to 2.0 3 10 6 cells/mL in 3D suspension cultures (Lei et al., 2014; Serra et al., 2012; Steiner et al., 2010; Wurm, 2004) . In addition, the synthetic hydrogel is chemically defined. Due to its thermoreversible nature, seeding and harvesting cells are simple and scalable. The system can be adapted to multiple scales-from the laboratory and toward the clinic-to support research in cell therapies, tissue engineering, and high-throughput drug discovery with hPSC-ECs. For instance, 50 mL hydrogel would be sufficient to produce 10 9 ECs for preclinical animal studies, and a bioreactor with 5 L of hydrogel could yield >10 11 ECs for clinical studies. The ability to move a (B) On day 0, single hPSCs are mixed with 10% PNIPAAm-PEG solution at 4 C and injected into the room-temperature E8 medium in the container. Fibrous hydrogels are instantly formed. Cells are cultured in E8 medium for 5 days, followed by an additional 5 days in EC differentiation medium. Medium is continuously perfused. On day 10, the hydrogel scaffold is liquefied, and spheroids are pelleted by centrifugation. Spheroids are dissociated into single cells by incubating in Accutase at 37 C for 10 min. Magnetic beads coated with anti-CD144 were added to pull down the CD144+ cells. single-culture system through multiple scales may aid clinical development.
Conclusion
We developed a scalable and GMP-compliant method for manufacturing ECs from hPSCs with high viability, high purity (>80%), and high yield (2.0 3 10 7 cells/mL hydrogel). These ECs had similar properties as ECs made using 2D culture systems. The method will make ECs broadly available and affordable for various applications. 
EXPERIMENTAL PROCEDURES
Culturing hPSCs in 3D PNIPAAm-PEG Hydrogels
To transfer the culture from 2D to 3D PNIPAAm-PEG hydrogels (Cosmo Bio, no. MBG-PMW20-5005), hPSCs maintained in Matrigel-coated six-well plates were treated with Accutase (Life Technologies, no. A1110501) at 37 C for 5 min and dissociated into single cells (Lei and Schaffer, 2013; Lei et al., 2014) . Dissociated cells were mixed with 10% PNIPAAm-PEG solution dissolved in E8 medium on ice and cast on tissue culture plates, then incubated at 37 C for 10 min to form hydrogels before adding warm E8 medium containing 10 mM ROCK inhibitor ([RI] , Y-27632, LC Laboratories, no. Y5301). The medium was changed daily. Cells were passaged every 5 days. To passage cells, the medium was removed, and 2 mL icecold PBS was added to dissolve the hydrogel for 5 min. Cell spheroids were collected by spinning at 100 3 g for 3 min. Cells were incubated in Accutase at 37 C for 10 min and dissociated into single cells.
EC Differentiation in 2D Cultures and in 3D Hydrogels
For 2D endothelial cell differentiation, hPSCs were dissociated with Accutase and plated on Matrigel at a density of 40,000 cells/cm 2 in E8 medium with 10 mM RI. After 24 hr, the medium was replaced with differentiation medium, consisting of N2B27 medium PeproTech, and 2 mM Forskolin (Sigma, no. F3917). The induction medium was changed after 1 day. ECs were harvested for analysis on day 5. For EC differentiation in 3D PEG hydrogel, single hPSCs were mixed with 10% PNIPAAm-PEG solution and cast on tissue culture plate, then incubated at 37 C for 10 min to form hydrogels before adding warm E8 medium containing 10 mM RI. Medium was changed daily. hPSCs were expanded for 5 days. E8 medium was removed and replaced with EC differentiation medium. After 3 days, the differentiation medium was replaced by EC induction medium. The induction medium was changed after 1 day. Cells were harvested for analysis on day 5.
Suspension Culturing in the Bioreactor
The bioreactor consists of a pump for medium perfusion, an oxygen-permeable plastic bag for stocking medium and a closed container (e.g., a 50-mL conical tube with a septa cap). On day 0, single iPSCs (4.0 3 10 6 cells) were mixed with 4 mL 10% PNIPAAm-PEG solution at 4 C and were injected into room-temperature E8 medium in the container. Fibrous hydrogels (with diameter <1.0 mm) were instantly formed. Cells were cultured in E8 medium for 5 days, followed by an additional 5 days of EC differentiation medium. Medium was continuously perfused. On day 10, hydrogel scaffolds were liquefied by perfusing ice-cold PBS. Spheroids were pelleted by centrifugation. Spheroids were dissociated into single cells by incubating in Accutase at 37 C for 10 min.
Magnetic beads coated with anti-CD144 antibodies (Miltenyi Biotec, were added to pull down ECs with a magnetic cell separator. The bioprocess was repeated twice.
Immunocytochemistry and Flow Cytometry
For 2D immunostaining, cells were fixed with 4% paraformaldehyde (PFA) at room temperature for 20 min, permeabilized with 0.25% Triton X-100 for 30 min and blocked with 5% donkey serum for 1 hr before incubating with primary antibodies (Table S1 ) at 4 C overnight. After extensive washing, secondary antibodies (Table S1 ) and 10 mM, DAPI in 2% BSA was added and incubated at room temperature for 4 hr. Cells were washed with PBS three times before imaging. For 3D immunostaining (spheroids), hPSCs were fixed with 4% PFA at room temperature for 30 min, and then incubated with PBS+ 0.25% Triton X-100+ 5% (vol/vol) goat serum+ primary antibodies at 4 C for 48 hr. After extensive washing, secondary antibodies in 2% BSA were added and incubated at 4 C for 24 hr.
Cells were washed with PBS three times before imaging with a confocal microscope. For flow cytometry analysis, the harvested cells were dissociated into single cells with Accutase. Single cells were fixed with 4% PFA and stained with primary antibodies (Table S1) Table S2 .
EB Differentiation
hPSCs were suspended in DMEM+ 20% FBS+ 10 mM b-mercaptoethanol in a low adhesion plate for 6 days. The cell masses were then transferred into plates coated with 0.1% gelatin and cultured in the same medium for another 6 days, followed by fixation and staining as described above.
Teratoma Formation In Vivo
The animal experiments were carried out following the protocols approved by the University of Nebraska-Lincoln Animal Care and Use Committee. hPSCs (3.0 3 10 6 ) were suspended in 25 mL PBS+ 25 mL Matrigel and injected subcutaneously at the back of the neck of the non-obese diabetic/severe combined immunodeficiency mice (female, age 7 weeks, Charles River Laboratory). Teratoma was harvested when its size reached 2 cm. Teratoma was fixed with 4% PFA for 48 hr, dehydrated with 70%, 95%, and 100% ethanol sequentially, and de-fated with xylene for 2 hr before embedded in paraffin. A 10-mm-thick section was cut and stained with H&E.
Statistical Analysis
Statistical analyses were done using the statistical package Instat (GraphPad Software, La Jolla, CA). For multiple comparisons, the means of triplicate samples were compared using the Tukey multiple comparisons analysis with the alpha level indicated in the figure legend.
ACCESSION NUMBERS
The accession numbers for the data reported in this paper are GEO: GSE99776 and GSE109683. All other data supporting the findings of this study are available within the paper and its Supplemental Information. Fork, C., Gu, L., Hitzel, J., Josipovic, I., Hu, J., Wong, M.S., Ponomareva, Y., Albert, M., Schmitz, S.U., Uchida, S., et al. (2015) . Table S1 . Antibodies used in this study (Related to Figure 1 , 2, 3, 6, 7and Figure S1 , 2, 3, 4, 5, 6). Table S2 . Real time qPCR primers used in this study (Related to Figure 3 and Figure S5 ). (Park et al., 2008) . hPSCs (H9s and iPSCs) were maintained in 6-welll plate coated with Matrigel (#354277, BD Biosciences) in Essential 8 TM medium (E8, #A1517001, Invitrogen). Cells were passaged every 4 days with 0.5 mM EDTA (#AM9260G, Invitrogen). Medium was changed daily. Cells were routinely checked for the expression of pluripotency markers, OCT3/4 and NANOG, their capability to form teratomas in immunodeficient mice, their karyotypes and bacterial contaminations. Human aortic vascular smooth muscle cells (VSMC, #CC-2571, Lonza) and HUVECs (#00191027, Lonza) were obtained from Lonza.
SUPPLEMENTAL INFORMATION
Primer
Culturing hPSCs in 3D PNIPAAm-PEG Hydrogels
To transfer the culture from 2D to 3D PNIPAAm-PEG hydrogels (#MBG-PMW20-5005, Cosmo Bio), hPSCs maintained in Matrigel-coated 6-welll plate were treated with Accutase (#A1110501, Life Technologies) at 37 °C for 5 minutes and dissociated into single cells (Lei and Schaffer, 2013; Lei et al., 2014) . Dissociated cells were mixed with 10% PNIPAAm-PEG solution dissolved in E8 medium on ice and cast on tissue culture plate, then incubated at 37 °C for 10 minutes to form hydrogels before adding warm E8 medium containing 10 μM ROCK inhibitor (RI, Y-27632, #Y5301, LC Laboratories). Medium was changed daily. Cells were passaged every 5 days. To passage cells, medium was removed, and 2 ml ice-cold PBS was added to dissolve the hydrogel for 5 minutes. Cell spheroids were collected by spinning at 100 g for 3 minutes. Cells were incubated in Accutase at 37 °C for 10 minutes and dissociated into single cells.
EC Differentiation in 2D cultures and in 3D hydrogels
For 2D endothelial cell differentiation, hPSCs were dissociated with Accutase and plated on Matrigel at a density of 40,000 cells/cm 2 in E8 medium with 10 μM RI. After 24 hours, the medium was replaced with differentiation medium, consisting of N2B27 medium (1:1 mixture of DMEM/F12 (#SH30004.04, HyClone) with Glutamax-I (#35050061, Life Technologies) and Neurobasal medium (#21103049, Life Technologies) supplemented with N2 (#17502048, Life Technologies) and B27 minus vitamin A (#12587010, Life Technologies) with 8 μM CHIR99021 (#C6556, LC laboratories) and 25 ng/mL BMP4 (#314BP010, R&D Systems). After 3 days, the differentiation medium was replaced by EC induction medium consisting of StemPro-34 SFM medium (#10639011, Life Technologies) supplemented with 200 ng/mL VEGFA (#100-20, PeproTech) and 2 μM Forskolin (#F3917, Sigma). The induction medium was changed after 1 day. ECs were harvested for analysis on day 5.
For EC differentiation in 3D PEG hydrogel, single hPSCs were mixed with 10% PNIPAAm-PEG solution and cast on tissue culture plate, then incubated at 37 °C for 10 minutes to form hydrogels before adding warm E8 medium containing 10 μM ROCK inhibitor. Medium was changed daily. hPSCs were expanded for 5 days. E8 medium was removed and replaced with EC differentiation medium. After 3 days, the differentiation medium was replaced by EC induction medium. The induction medium was changed after 1 day. Cells were harvested for analysis on day 5.
Suspension Culturing in the Bioreactor
The bioreactor consists of a pump for medium perfusion, an oxygen-permeable plastic bag for stocking medium and a closed container (e.g. a 50-mL conical tube with a septa cap). On day 0, single iPSCs (~4.0x10 6 cells) were mixed with 4 mL 10% PNIPAAm-PEG solution at 4 °C, and were injected into room temperature E8 medium in the container. Fibrous hydrogels (with diameter < 1.0 mm) were instantly formed. Cells were cultured in E8 medium for 5 days, followed by additional 5 days of EC differentiation medium. Medium was continuously perfused. On day 10, hydrogel scaffolds were liquefied by perfusing ice-cold PBS. Spheroids were pelleted by centrifugation. Spheroids were dissociated into single cells through incubating in Accutase at 37 °C for 10 minutes. Magnetic beads coated with anti-CD144 antibodies (cat #130-097-857, Miltenyi Biotec) were added to pull down ECs with a magnetic cell separator. The bioprocess was repeated 2 times.
Immunocytochemistry and Flow Cytometry
For 2D immunostaining, cells were fixed with 4% paraformaldehyde (PFA) at room temperature for 20 minutes, permeabilized with 0.25% Triton X-100 for 30 minutes and blocked with 5% donkey serum for 1 hour before incubating with primary antibodies (Table S1 ) at 4 °C overnight. After extensive washing, secondary antibodies (Table S1) and 10 µM 4',6-Diamidino-2-Phenylindole (DAPI) in 2% BSA were added and incubated at room temperature for 4 hours. Cells were washed with PBS for 3 times before imaging.
For 3D immunostaining (spheroids), hPSCs were fixed with 4% PFA at room temperature for 30 minutes, and then incubated with PBS + 0.25% Triton X-100 + 5% (vol/vol) goat serum + primary antibodies at 4 °C for 48 hours. After extensive washing, secondary antibodies in 2% BSA were added and incubated at 4 °C for 24 hours. Cells were washed with PBS for three times before imaging with a confocal microscope.
For flow cytometry analysis, the harvested cells were dissociated into single cells with Accutase. Single cells were fixed with 4% PFA and stained with primary antibodies (Table  S1 ) at 4 °C overnight. After 3 times washing with 1% BSA in PBS, secondary antibodies were added and incubated at room temperature for 2 hours. Cells were washed with 1% BSA in PBS and analyzed using Cytek flow cytometry.
RNA Extraction, cDNA Synthesis and Quantitative PCR
Total RNAs for qPCR and RNA sequencing were extracted from 2D-ECs and 3D-ECs on day 5 of the differentiation using Trizol (#15596018, Invitrogen), according to the manufacturer's instructions. Reverse transcription is done with the Maxima First Strand cDNA Synthesis Kit (#K1642, Life Technologies). Quantitative real-time PCR was carried out in an Eppendorf MasterCycler RealPlex4 (ThermoFisher Scientific) using the Power SYBR Green PCR Master Mix (#4367659, ThermoFisher), according to the manufacturer's instructions. The data were normalized to the endogenous GAPDH. Primer sequence were listed in Table S2 .
Embryoid Body (EB) Differentiation hPSCs were suspended in DMEM + 20% FBS + 10 μM β-mercaptoethanol in a low adhesion plate for 6 days. The cell masses were then transferred into plates coated with 0.1% gelatin and cultured in the same medium for another 6 days, followed by fixation and staining as described above.
Teratoma Formation in vivo
The animal experiments were carried out following the protocols approved by the University of Nebraska-Lincoln Animal Care and Use Committee. 3.0x10 6 hPSCs were suspended in 25 µl PBS + 25 µl Matrigel and injected subcutaneously at the back of the neck of the NOD-SCID mice (female, age 7 weeks, Charles River Laboratory). Teratoma was harvested when its size reached 2 cm. Teratoma was fixed with 4% PFA for 48 hours, dehydrated with 70%, 95% and 100% ethanol sequentially, and de-fated with xylene for 2 hours before embedded in paraffin. 10 µm thick section was cut and stained with hematoxylin and eosin.
Tube Formation
200 μl of Matrigel was added into each well of a 12-well plate and incubated for 30 minutes at 37 °C to allow forming a thin layer of hydrogel. 80,000 hPSC-ECs pre-stained with DiI (#V22889, Vybrant multicolor cell-labeling kit, Fisher Scientific) were then seeded onto the hydrogel and cultured for 24 hours at 37 °C. Cells were fixed with 4% PFA for 10 minutes and analyzed using Zeiss fluorescence microscope.
Co-culture Assay of hPSC-ECs and VSMCs
hPSC-ECs and VSMCs were pre-stained with DiI (red) and DiO (green), respectively, according to the manufacturer's instructions. 2.0x10 4 hPSC-ECs/cm 2 and 2.0x10 4 VSMCs/cm 2 were co-plated and cultured in StemPro-34 SFM supplemented with 50 ng/ml VEGF-A for 24 hours. Cells were fixed with 4% PFA for 10 minutes and analyzed using a fluorescence microscope.
Uptake of Dil-Ac-LDL
On day 5 differentiation, ECs were replated on human fibronectin (#F1141, Sigma)-coated dishes. Cells were incubated with 2.5 g/mL DiI-Ac-LDL-Alexa597 (#L3484, Molecular Probes/Life Technologies) in StemPro-34 medium for 4 hours at 37 °C. Thereafter, cells were washed three times with PBS and fixed with 4% PFA for 10 minutes. DNA was counterstained with DAPI. Cellular uptake of DiI-Ac-LDL-Alexa 597 was visualized with a fluorescence microscope (Zeiss).
Trans-Endothelial Electrical Resistance (TEER)
hPSC-ECs were seeded at a density of 1×10 6 cells/mL on 24-well cell culture inserts (0.4 μM pore size, cat # 3470, Corning) coated with fibronectin. Cells were grown for 72 hours in EGM-2 medium. The medium was then changed to starvation medium (basal EBM medium +0.5% FBS) with or without vascular permeability factors (100 ng/mL TNF-α (cat # 300-01A, Peprotech) or 100 ng/mL IL-1β (cat # 200-01B, Peprotech) or 100 ng/mL VEGF-A) for 30 hours. Trans-endothelial electrical resistance was recorded using the Digital AC/DC Clamp Meter (cat # MS2101, MASTECH). This experiment was performed in triplicates for each condition and repeated 3 times. Results are depicted as the steadystate TEER values with blank filter subtracted.
Glycolysis
Cell glycolysis were analyzed using the Glycolysis Assay Kit (cat # 600450, Cayman Chemical) according to the manufacturer's instruction. Briefly, on day 5 of the differentiation, 10 μl cell culture medium was collected and mixed with 90 μl assay buffer. Then, 100 μl reaction solution was added to each well, and the plate was incubated with gentle shaking for 30 minutes at room temperature. A plate reader was used to read the absorbance at 490 nm.
Matrigel Plug Assay
Animal procedures were performed in accordance with an IACUC-approved protocol reviewed by the University of Nebraska-Lincoln Animal Care and Use Committee. 6-8-week-old SCID mice (Charles River Laboratory) were used. hPSC-ECs were added to the Matrigel to a final concentration of 10 million cells/mL. The Matrigel (300 μl) was then immediately implanted subcutaneously to the dorsal flank of the mouse. Implants were harvested for analysis 14 days later. Hematoxylin & eosin staining, and immunostaining was performed to analyze the tube formation potential in vivo.
RNA Sequencing and Data Analysis
Total RNAs of 2D-ECs and 3D-ECs (e.g. day 5 cells of the differentiation) were prepared with RNeasy mini kit (cat # 74104 QIAGEN) according to the manufacturer's instruction. Libraries were prepared with TruSeq Stranded mRNA Library Prep Kit and sequenced with Illumina NextSeq 500. 20 million 75 bp paired-end reads were generated for each sample. The reads were trimmed to make sure the average quality score was larger than 30 and the minimum length was 40 bp. All trimmed short reads were mapped to the human Genome (version hg19) using TopHat, allowing up to two base mismatches per read. Reads mapped to multiple locations were discarded. Numbers of reads in genes were counted by the HTSeq-count tool using corresponding human gene annotations and the "union" resolution mode. For normalization and pair-wise comparisons, differentially expressed genes were identified by using DEseq to analyze the numbers of reads aligned to genes. The thresholds for differential expression were set at fold-change > 2 and adjusted P-values < 0.001 for the null hypothesis.
PCA Analysis
Principle Component Analysis (PCA) was implemented with R function prcomp and the 2D PCA plot was produced with R package rgl. For PCA analysis, genes with zero reads were discarded and a natural log transformation was applied to the number of reads for each gene. The proportion of total variance suggested that those two PCs (PC1 51.8% and PC2 21.2%) are sufficient to describe the major changing pattern of all samples.
Heatmap for Gene Expression
For each pathway, the expression values of genes in the given pathway were extracted and, to further stabilize the variance, a natural log transformation was applied to normalized read numbers for genes. The heatmap of expression profiles for genes in a given pathway was plotted with R package heatmap. In the heatmap, dark orange indicates high expression while blue represents low expression.
Western Blotting
On day 5 of the differentiation, 2D-ECs or 3D-ECs were harvested and cell lysates were prepared using the Pierce IP™ lysis buffer (cat # 87788, ThermoFisher) supplemented with Halt™ Protease & Phosphatase Single-Use Inhibitor Cocktail (100x, cat # 78442, ThermoFisher). 30 μg of total proteins for each sample were subjected to SDS-PAGE analysis on a 4%-12% NuPAGE™ Bis-Tris protein gel (cat # NP0321BOX, ThermoFisher). GAPDH was used as a loading control.
Statistical Analysis
Data Availability
The final processed data and raw fastq files were submitted to Gene Expression Omnibus (GEO) with the accession number GSE99776 and GSE109683. All other data supporting the findings of this study are available within the paper and its Supplementary Information.
